Your browser doesn't support javascript.
loading
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.
Sun, Clare; Nierman, Pia; Kendall, Ellen K; Cheung, Jean; Gulrajani, Michael; Herman, Sarah E M; Pleyer, Christopher; Ahn, Inhye E; Stetler-Stevenson, Maryalice; Yuan, Constance M; Maric, Irina; Gaglione, Erika M; Harris, Hailey M; Pittaluga, Stefania; Wang, Min Hui; Patel, Priti; Farooqui, Mohammed Z H; Izumi, Raquel; Hamdy, Ahmed; Covey, Todd; Wiestner, Adrian.
Afiliación
  • Sun C; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Nierman P; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Kendall EK; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Cheung J; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Gulrajani M; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Herman SEM; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Pleyer C; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Ahn IE; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Stetler-Stevenson M; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, and.
  • Yuan CM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, and.
  • Maric I; Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; and.
  • Gaglione EM; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Harris HM; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, and.
  • Wang MH; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Patel P; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Farooqui MZH; Hematology Branch, National Heart, Lung, and Blood Institute.
  • Izumi R; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Hamdy A; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Covey T; Acerta Pharma, a member of the AstraZeneca Group, South San Francisco, CA.
  • Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute.
Blood ; 136(1): 93-105, 2020 07 02.
Article en En | MEDLINE | ID: mdl-32202637
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Linfocítica Crónica de Células B / Inhibidores de Proteínas Quinasas / Agammaglobulinemia Tirosina Quinasa / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged80 Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Benzamidas / Leucemia Linfocítica Crónica de Células B / Inhibidores de Proteínas Quinasas / Agammaglobulinemia Tirosina Quinasa / Proteínas de Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged80 Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos